Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin

References

• Duval, M., Suciu, S., Ferster, A., Rialland, X., Nelken, B., Lutz, P., et al. (2002) "Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer—Children's Leukemia Group phase 3 trial", Blood, 99(8), 2734 — 2739.
   Google Scholar
• Amylon, M.D., Shuster, J., Pullen, J., Berard, C., Link, M.P., Wharam, M., et al. (1999) "Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study", Leukemia, 13(3), 335— 342.
   Google Scholar
• Gokbuget, N. and Hoelzer, D. (2002) "Recent approaches in acute lymphoblastic leukemia in adults", Rev. Clin. Exp. Hematol., 6(2), 114 — 141; discussion 200–202.
   Google Scholar
• Larson, R.A., Dodge, R.K., Burns, C.P., Lee, E.J., Stone, R.M., Schulman, P., et al. (1995) "A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811", Blood, 85(8), 2025— 2037.
   Google Scholar
• Andrew, M., Brooker, L. and Mitchell, L. (1994) "Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukaemia", Blood Coagul. Fibrino-lysis 5(1), S24 —S36; discussion S59—S64.
   Google Scholar
• Nowak-Gottl, U., Heinecke, A., von Kries, R., Nurnberger, W., Munchow, N. and Junker, R. (2001) "Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of con-comitant Escherichia coli asparaginase/prednisone administration", Thromb. Res., 103(3), 165–172.
   Google Scholar
• Nowak-Gottl, U., Wermes, C., Junker, R., Koch, HG., Schobess, R., Fleischhack, G., et al. (1999) "Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors", Blood, 93(5), 1595— 1599.
   Google Scholar
• Mitchell, L.G., Andrew, M., Hanna, K., Abshire, T., Halton, J., Anderson, R., et al. (2003) "A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study", Cancer, 97(2), 508 — 516.
   Google Scholar
• Gugliotta, L., Mazzucconi, M.G., Leone, G., Mattioli-Belmonte, M., Defazio, D., Annino, L., et al. (1992) "Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group", Eur. J. Haematol., 49(2), 63— 66.
   Google Scholar
• Rowe, J.M., Richards, S., Wiernik, PH., et al. (1999) "Allogeneic bone marrow transplantation for adults with acute lymphoblastic leukemia in first complte remission: Early results from the international ALL trial (MRC UKALL/ECOG E2993)", Blood, 94, 732a.
   Google Scholar
• Larson, R.A., Dodge, R.K., Linker, CA., Stone, R.M., Powell, B.L., Lee, E.J., et al. (1998) "A randomized controlled trial of filgrastirn during remission induction and consolidation chemother-apy for adults with acute lymphoblastic leukemia: CALGB study 9111", Blood, 92(5), 1556–1564.
   Google Scholar
• Alberts, SR., Bretscher, M., Wiltsie, J.C., O'Neill, B.P., Mokri, B. and Witzig, T.E. (1999) "Thrombosis related to the use of L-asparaginase in adults with acute lymphoblastic leukemia: a need to consider coagulation monitoring and clotting factor replacement", Leuk. Lymphoma, 32(5–6), 489–496.
   Google Scholar
• Mitchell, L., Hoogendoorn, H., Giles, A.R., Vegh, P. and Andrew, M. (1994) "Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complica-tions in L-Asparaginase-induced antithrombin III deficiency", Blood, 83(2), 386— 391.
   Google Scholar
• Leone, G., Gugliotta, L., Mazzucconi, M.G., De Stefano, V., Belmonte, MM., Dragoni, F., et al. (1993) "Evidence of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L-asparaginase: a GIMEMA study", Thromb. Haemost., 69(1), 12–15.
   Google Scholar
• Marra, R., Pagano, L., De Stefano, V., Leone, G. and Bizzi, B. (1986) "Antithrombin III during high-dose cytosine arabinoside therapy with or without asparaginase", Acta Haematol., 75(2), 96 — 99.
   Google Scholar
• Nowak-Gottl, U., Ahlke, E., Fleischhack, G., Schwabe, D., Schobess, R., Schumann, C., et al. (2003) "Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration", Blood, 101(7), 2529 — 2533.
   Google Scholar
• Giordano, P., Carlo Del Vecchio, R., Santoro Nicola, et al. (2000) "Thrombin generation in children with acute lymphoblastic leukemia: effect of immunophenotypic subgroups", Pediatr. Hema-tol. Oncol., 17, 667–672.
   Google Scholar
• Barbui, T., Finazzi, G., Grassi, A. and Marchioli, R. (1996) "Thrombosis in cancer patients treated with hematopoietic growth factors— a meta-analysis. On behalf of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the ISTH. Thrombosis & Haemostasis", 75(2), 368 — 371.
   Google Scholar
• Verso, M. and Agnelli, G. (2003) "Venous thromboembolism associated with long-term use of central venous catheters in cancer patients", Journal of Clinical Oncology, 21(19), 3665–3675.
   Google Scholar
• Bucur, S.Z., Levy, J.H., Despotis, G.J., Spiess, B.D. and Hillyer, C.D. (1998) "Uses of antithrombin III concentrate in congenital and acquired deficiency states", Transfusion, 38(5), 481 —498.
   Google Scholar
• Mazzucconi, M.G., Gugliotta, L., Leone, G., Dragoni, F., Belmonte, MM., De Stefano, V., et al. (1994) "Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study", Blood Coagul. Fibrinolysis, 5(1), 23–28.
   Google Scholar
• Gugliotta, L., D'Angelo, A., Mattioli Belmonte, M., Vigano-D'Angelo, S., Colombo, G., Catani, L., et al. (1990) "Hypercoagul-ability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivo", Br. J. Haematol., 74(4), 465 —470.
   Google Scholar
• Mattioli Belmonte, M., Gugliotta, L., Delvos, U., Catani, L., Vianelli, N., Cascione, M.L., et al. (1991) "A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase", Haematologica, 76(3), 209 — 214.
   Google Scholar
• Elhasid, R., Lanir, N., Sharon, R., Weyl Ben Arush, M., Levin, C., Postovsky, S., et al. (2001) "Prophylactic therapy with enoxaparin during L-asparaginase treatment in children with acute lympho-blastic leukemia", Blood Coagul. Fibrinolysis, 12(5), 367 — 370.
   Google Scholar